Literature DB >> 10443890

Frequency of tau mutations in three series of non-Alzheimer's degenerative dementia.

H Houlden1, M Baker, J Adamson, A Grover, S Waring, D Dickson, T Lynch, B Boeve, R C Petersen, S Pickering-Brown, F Owen, D Neary, D Craufurd, J Snowden, D Mann, M Hutton.   

Abstract

Splice-site and missense mutations have been identified in tau associated with frontotemporal dementia with parkinsonism linked to chromosome 17. In this study we assessed the genetic contribution of tau mutations to three patient series with non-Alzheimer's (non-AD) degenerative dementia. The groups included (1) a community-based dementia series from Minnesota, MN; (2) a referral series with clinicopathological tauopathy; and (3) a pathologically confirmed familial frontotemporal dementia series from Manchester, UK. Comparing the three clinical series: in the stringently diagnosed Manchester frontotemporal dementia series, tau mutations were present in 13.6% of cases (three splice-site mutations); in the clinicopathological referral series that used more general inclusion criteria, 3 cases with P301L mutations were observed, which represents a lower mutation frequency of 3.6% (9.4% in familial cases); in contrast, tau mutations were not detected in the Minnesota community-based dementia series, suggesting the occurrence of these mutations in dementia generally is rare (<0.2%). These data identify the prevalence of mutations in three different clinical settings and indicate that this figure is sensitive to the diagnostic criteria used in each patient series.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10443890     DOI: 10.1002/1531-8249(199908)46:2<243::aid-ana14>3.0.co;2-l

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  17 in total

Review 1.  Cellular factors modulating the mechanism of tau protein aggregation.

Authors:  Sarah N Fontaine; Jonathan J Sabbagh; Jeremy Baker; Carlos R Martinez-Licha; April Darling; Chad A Dickey
Journal:  Cell Mol Life Sci       Date:  2015-02-11       Impact factor: 9.261

Review 2.  Fast axonal transport misregulation and Alzheimer's disease.

Authors:  Gerardo Morfini; Gustavo Pigino; Uwe Beffert; Jorge Busciglio; Scott T Brady
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

3.  Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications.

Authors:  M Sjögren; S Folkesson; K Blennow; E Tarkowski
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

4.  FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.

Authors:  Hazel Urwin; Keith A Josephs; Jonathan D Rohrer; Ian R Mackenzie; Manuela Neumann; Astrid Authier; Harro Seelaar; John C Van Swieten; Jeremy M Brown; Peter Johannsen; Jorgen E Nielsen; Ida E Holm; Dennis W Dickson; Rosa Rademakers; Neill R Graff-Radford; Joseph E Parisi; Ronald C Petersen; Kimmo J Hatanpaa; Charles L White; Myron F Weiner; Felix Geser; Vivianna M Van Deerlin; John Q Trojanowski; Bruce L Miller; William W Seeley; Julie van der Zee; Samir Kumar-Singh; Sebastiaan Engelborghs; Peter P De Deyn; Christine Van Broeckhoven; Eileen H Bigio; Han-Xiang Deng; Glenda M Halliday; Jillian J Kril; David G Munoz; David M Mann; Stuart M Pickering-Brown; Valerie Doodeman; Gary Adamson; Shabnam Ghazi-Noori; Elizabeth M C Fisher; Janice L Holton; Tamas Revesz; Martin N Rossor; John Collinge; Simon Mead; Adrian M Isaacs
Journal:  Acta Neuropathol       Date:  2010-05-20       Impact factor: 17.088

5.  The heritability and genetics of frontotemporal lobar degeneration.

Authors:  J D Rohrer; R Guerreiro; J Vandrovcova; J Uphill; D Reiman; J Beck; A M Isaacs; A Authier; R Ferrari; N C Fox; I R A Mackenzie; J D Warren; R de Silva; J Holton; T Revesz; J Hardy; S Mead; M N Rossor
Journal:  Neurology       Date:  2009-11-03       Impact factor: 9.910

6.  Association of GSK3B with Alzheimer disease and frontotemporal dementia.

Authors:  Barbara A J Schaffer; Lars Bertram; Bruce L Miller; Kristina Mullin; Sandra Weintraub; Nancy Johnson; Eileen H Bigio; Marsel Mesulam; Martina Wiedau-Pazos; George R Jackson; Jeffrey L Cummings; Rita M Cantor; Allan I Levey; Rudolph E Tanzi; Daniel H Geschwind
Journal:  Arch Neurol       Date:  2008-10

7.  Patient care and management of frontotemporal lobar degeneration.

Authors:  Lauren Massimo; Murray Grossman
Journal:  Am J Alzheimers Dis Other Demen       Date:  2008 Apr-May       Impact factor: 2.035

8.  Frequency of tau mutations in familial and sporadic frontotemporal dementia and other tauopathies.

Authors:  Prudence M Stanford; William S Brooks; Erdahl T Teber; Marianne Hallupp; Catriona McLean; Glenda M Halliday; Ralph N Martins; John B J Kwok; Peter R Schofield
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

9.  Novel tau polymorphisms, tau haplotypes, and splicing in familial and sporadic frontotemporal dementia.

Authors:  Maria-Jesús Sobrido; Bruce L Miller; Necat Havlioglu; Victoria Zhukareva; Zhihong Jiang; Ziad S Nasreddine; Virginia M-Y Lee; Tiffany W Chow; Kirk C Wilhelmsen; Jeffrey L Cummings; Jane Y Wu; Daniel H Geschwind
Journal:  Arch Neurol       Date:  2003-05

10.  Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland.

Authors:  Anna-Lotta Kaivorinne; Johanna Krüger; Katja Kuivaniemi; Hannu Tuominen; Virpi Moilanen; Kari Majamaa; Anne M Remes
Journal:  BMC Neurol       Date:  2008-12-17       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.